CVRx, Inc.

CVRX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $56.7M $51.3M $39.3M $22.5M $13.0M $6.1M
Cost of Revenue $8.3M $8.3M $6.3M $5.0M $3.6M $1.4M
Gross Profit $48.3M $43.0M $33.0M $17.5M $9.4M $4.6M
Gross Margin 85.3% 83.8% 84.1% 77.8% 72.1% 76.2%
Operating Expenses
Research & Development $11.1M $11.1M $11.6M $10.0M $7.5M $6.4M
SG&A Expense $88.5M $91.3M $64.5M $50.0M $27.9M $9.7M
Operating Income $-51.3M $-59.5M $-43.1M $-42.5M $-26.0M $-11.5M
Operating Margin -90.5% -116.0% -109.7% -189.3% -199.2% -190.2%
Interest Expense $1.8M $165.0K $2.2M $2.5M
Pretax Income $-53.3M $-59.9M $-41.1M $-41.3M $-43.0M $-14.0M
Income Tax Expense $-18.0K $55.0K $147.0K $109.0K $91.0K $85.0K
Net Income $-53.3M $-60.0M $-41.2M $-41.4M $-43.1M $-14.1M
Net Margin -94.1% -116.9% -104.8% -184.4% -330.5% -233.1%
EPS (Basic) $-2.04 $-2.65 $-1.99 $-2.02 $-4.16 $-37.01
EPS (Diluted) $-2.04 $-2.65 $-1.99 $-2.02 $-4.16 $-37.01
Shares Outstanding (Basic) 26.1M 22.6M 20.8M 20.5M 10.4M 360.4K
Shares Outstanding (Diluted) 26.1M 22.6M 20.8M 20.5M 10.4M 360.4K
Dividends Per Share